Similarly, the expression levels of TRIB3, RRM2, NT5DC2, and CISD1 increased with the clinical stages of HCC (Figure 4E), while TF and ALB displayed the opposite trend. This evidence concerns the gene ALB and hepatocellular carcinoma.